Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1

Renal cell carcinoma (RCC) is the second most common human urinary tumor. Eupatilin is the main active ingredient of the traditional Chinese medicine Artemisia asiatica. The effect of Eupatilin on RCC and the underlying mechanism remain unknown. Here, we investigated the anticancer effects and mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Weifeng, Wu, Zhiming, Chen, Nanhui, Zhong, Kaihua, Lin, Yifeng, Jiang, Huiming, Wan, Pei, Lu, Shanming, Yang, Lawei, Liu, Siping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507163/
https://www.ncbi.nlm.nih.gov/pubmed/31179326
http://dx.doi.org/10.1155/2019/5016483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507163/
https://www.ncbi.nlm.nih.gov/pubmed/31179326
http://dx.doi.org/10.1155/2019/5016483

Ejemplares similares